This is an observational study that will monitor clinical outcomes of patients who have received a NiCord®/CordIn™ (omidubicel) transplant as part of a GC clinical interventional study and meet the eligibility criteria for this Long Term Follow Up study.
Study Type
OBSERVATIONAL
Enrollment
33
UCSF Benioff Children's Hospital
Oakland, California, United States
Loyola University, Cardinal Bernardin Cancer Center
Maywood, Illinois, United States
Duke University Medical Center
Durham, North Carolina, United States
long term sustained chimerism of NiCord®/CordIn™ (omidubicel) transplantation
Time frame: 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Duke University Medical Center
Durham, North Carolina, United States
Vanderbilt
Nashville, Tennessee, United States
University Medical Center Utrecht
Utrecht, Netherlands
National University Cancer Institute
Singapore, Singapore
Singapore General Hospital
Singapore, Singapore
University Hospital Vall D'Hebron
Barcelona, Spain
Hospital Universitario La Fe
Valencia, Spain